Angiotensin II and the heart on the intracrine renin-angiotensin system

Hypertension

Volumn 35, Issue 6, 2000, Pages 1183-1188

  De Mello, Walmor C ^b   Danser, A H Jan ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Angiotensin; Heart; Hypertrophy; Receptors, angiotensin; Renin; Signal transduction

Indexed keywords

HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0343627693     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.6.1183     Document Type: Review

References (91)

1. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol. 1987;59(suppl A): 59A-65A.
2. Jin M, Wilhelm MJ, Lang RE, Unger T, Lindpaintner K, Ganten D. Endogenous tissue renin-angiotensin systems. From molecular biology to therapy. Am J Med. 1988;84(suppl 3A):28-36.
3. Baker KM, Campanile MP, Trachte GJ, Peach MJ. Identification and characterization of the rabbit angiotensin II myocardial receptor. Circ Res. 1984;54:286-293.
4. Rioux F, Park WF, Regoli D. Characterization of angiotensin receptors in rabbit isolated atria. Can J Physiol Pharmacol. 1975;54:229-237.
5. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans P. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;165:196-203.
6. Hein L. Genetic deletion and overexpression of angiotensin II receptors. J Mol Med. 1998;76:756-763.
7. Sasaki K, Yamano Y, Bardham S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991; 351:230-233.
8. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
9. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem. 1993;268: 24539-24542.
10. Clauser E. Molecular structure and function of angiotensin II receptors. Nephrologie. 1998;19:403-410.
11. Inagami T, Guo DF, Kitami Y. Molecular biology of angiotensin II receptors: an overview. J Hypertens. 1994;12(suppl):S83-S94.
12. Dzau VJ, Mukoyama M, Pratt RE. Molecular biology of angiotensin II receptors: target for drug research? J Hypertens. 1994;12(suppl):S1-S5.
13. Samyn ME, Petershak JA, Bedell KA, Mathews MS, Segar JL. Ontogeny and regulation of cardiac angiotensin type 1 and 2 receptors during fetal life in sheep. Pediatr Res. 1998;44:323-329.
14. Price RL, Carver W, Simpson DG, Fu L, Zhao J, Borg TK, Terracio L. The effects of angiotensin II and specific angiotensin receptors blockers on embryonic cardiac development and looping patterns. Dev Biol. 1997; 192:572-584.
15. 1b) by a protein kinase C independent mechanism. Hypertens Res. 1997;20:295-300.
16. Anderson KM, Murahashi T, Dostal DE, Peach MJ. Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am J Physiol. 1993;264:C179-C188.
17. 2 receptor degradation is prevented by ligand occupation. Biochem Biophys Res Commun. 1998;243:142-147.
18. 2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 1997;11: 1266-1277.
19. 1) in the heart with anti-peptide antibodies showing a chronotropic effect. Receptors Channels. 1998;6:99-111.
20. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54: 227-241.
21. Re RN, Vizard DL, Brown J, LeGros L, Bryan SE. Angiotensin II receptor in chromatin. J Hypertens. 1984;2(suppl 1):S271-S173.
22. Sen I, Rajasekaran AK. Angiotensin II-binding protein in adult and neonatal rat heart. J Mol Cell Cardiol. 1991;23:563-572.
23. De Mello WC. Is an intracellular renin angiotensin system involved in the control of cell communication in heart? J Cardiovasc Pharmacol. 1994; 23:640-646.
24. Haller H, Lindschau C, Quass P, Luft FC. Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol. 1999;(suppl 11):S75-S83.
25. Thomas WG, Thekkumbara TJ, Baker KM. Cardiac effects of angiotensin II AT1 receptor signaling, desensitization and internalization. Adv Exp Med Biol. 1996;396:59-69.
26. van Kesteren CAM, van Heugten HAA, Lamers JMJ, Saxena PR, Schalekamp MADH, Danser AHJ. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol. 1997;29:2147-2157.
27. Bartunek J, Weinberg EO, Tajima M, Rohrbach S, Lorrel BH. Angiotensin II type-2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied rats. Circulation. 1999;99:22-25.
28. Ijima K, Geshi E, Nomizo A, Arata Y, Katagiri T. Alteration in sarcoplasmic reticulum and angiotensin II type 1 receptor gene expression after myocardial infarction in rats. Jpn Circ J. 1998;62:449-454.
29. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1192.
30. Nakajima M, Hutchinson H, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92: 10663-10667.
31. Huang XC, Richards EM, Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem. 1996;271:15635-15641.
32. 2-receptor activation, bradykinin and prostaglandins. J Am Coll Cardiol. 1998;32:1787-1796.
33. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effect of angiotensin convening enzyme inhibitors and angiotensin II type 1 antagonists in rat heart failure. J Clin Invest. 1997;99:1926-1935.
34. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type-2 receptor research in the cardiovascular system. Hypertension. 1999;33:613-621.
35. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi Y, Shibazaki Y, et al. Angiotensin II type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathie hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 1997;96:3954-3962.
36. 2 receptors in the normal and failing human heart. J Pharmacol Exp Ther. 1998;284:323-336.
37. Brink M, Erne P, de Gasparo M, Rogg H, Schmid A, Stulz P, Bullock G. Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol. 1996;28:1789-1799.
38. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997;29:859-870.
39. Tamura M, Wanaka Y, Landon EJ, Inagami T. Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12W cells. Hypertension. 1999;33:626-632.
40. Lehtonen JA, Horiuchi M, Dzau VJ. Ceramide as a second messenger for angiotensin II type 2 receptor-mediated apoptosis. Circulation. 1997; 96(suppl I):I-554. Abstract.
41. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Inamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem. 1995;270:18719-18722.
42. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II-type 2 receptor. Nature. 1995;377:748-750.
43. Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I. Angiotensin II type-1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation. 1999;100: 2093-2999.
44. Masaki H, Kurihara T, Yamaki A, Inomoto N, Nozawa Y, Mori Kurihara T, Yamaki A, Inomoto N, Nozawa Y, Mori Y, et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 1998;101:527-535.
45. 1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophie cardiomyopathy. Hypertension. 1998;32:825-830.
46. Schmieder RE, Erdmann J, John S, Delles C, Jacobi J, Fleck E, Hilgers K, Regitz-Zagrosek V. Angiotensin II type 2 receptor gene variant modifies left ventricular structure in humans. Circulation. 1999; 100(suppl I):I-754. Abstract.
47. Danser AHJ, van Kats JP, Admiraal PJJ, Derkx FWM, Lamers JMJ, Verdouw PD, Saxena PR, Schalekamp MADH. Cardiac renin and angiotensins: uptake from plasma versus in situ synthesis. Hypertension. 1994; 24:37-48.
48. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993;22:513-522.
49. Leenen FHH, Skarda V, Yuan B, White R. Changes in cardiac Ang II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol. 1999;276:H317-H325.
50. van Kats JP, Danser AHJ, van Meegen J, Sassen LMA, Verdouw PD, Schalekamp MADH. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation. 1998;98:73-81.
51. 1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension. 1997;30:42-49.
52. Passier RCJJ, Smits JFM, Verluyten MJA, Daemen MJAP. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol. 1996;271:H1040-H1048.
53. Dzau VJ, Ellison KE, Brody T, Ingelfinger J, Pratt RE. A comparative study of the distributions of renin an angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology. 1987;120: 2334-2338.
54. Boer PH, Ruzicka M, Lear W, Harmsen E, Rosenthal J, Leenen FHH. Stretch-mediated activation of cardiac renin gene. Am J Physiol. 1994; 36:H1630-H1636.
55. Katz SA, Opsahl JA, Lunzer MM, Forbis LM, Hirsch AT. Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension. 1997;30:259-266.
56. de Lannoy LM, Danser AHJ, van Kats JP, Schoemaker RG, Saxena PR, Schalekamp MADH. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart: local production of angiotensin I. Hypertension. 1997;29:1240-1251.
57. de Lannoy LM, Danser AHJ, Bouhuizen AMB, Saxena PR, Schalekamp MADH. Localization and production of angiotensin II in the isolated perfused rat heart. Hypertension. 1998;31:1111-1117.
58. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res. 1995;767: 258-265.
59. van Kesteren CAM, Saris JJ, Dekkers DHW, Lamers JMJ, Saxena PR, Schalekamp MADH, Danser AHJ. Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II. Cardiovasc Res. 1999;43:148-156.
60. Heller LJ, Opsahl JA, Wernsing SE, Saxena R, Katz SA. Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy. Am J Physiol. 1998;274:R849-R856.
61. Sealey JE, Catanzaro D, Lavin TN, Gahnem F, Pitaresi T, Lu H-F, Laragh JH. Specific prorenin/renin binding (ProBP): identification and characterization of a novel membrane site. Am J Hypertens. 1996;9:491-502.
62. Danser AHJ, van Kesteren CAM, Bax WA, Tavenier M, Derkx FHM, Saxena PR, Schalekamp MADH. Prorenin, renin, angiotensinogen and ACE in normal and failing human hearts: evidence for renin-binding. Circulation. 1997;96:220-226.
63. van Kesteren CAM, Danser AHJ, Derkx FHM, Dekkers DHW, Lamers JMJ, Saxena PR, Schalekamp MADH. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension. 1997;30:1389-1396.
64. Admiraal PJJ, van Kesteren CAM, Danser AHJ, Derkx FHM, Sluiter W, Schalekamp MADH. Uptake and proteolytic activation of prorenin by cultured human endothelial cells. J Hypertens. 1999;17:621-629.
65. Lindpainter K, Lu W, Niedermajer N, Schieffer B, Just H, Ganten D, Drexler H. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 1993;23:133-143.
66. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation. 1995;92:2690-2696.
67. Passier RCJJ, Smits JFM, Verluyten MJS, Studer R. Drexler R, Daemen MJAP. Activation of angiotensin converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol. 1995;269: H1268-H1276.
68. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86: 1913-1920.
69. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn FAO. Localization of angiotensin converting enzyme in rat heart. Circ Res. 1991;68:141-149.
70. Falkenhahn M, Franke F, Bohle RM, Zhu Y-C, Stauss HM, Bachmann S, Danilov S, Unger T. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension. 1995;25:219-226.
71. Ruzicka M, Skarda V, Leenen FHH. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation. 1995;92:3568-3573.
72. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. 1995;92:3105-3112.
73. Nasjletti A. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension. 1997;31:194-200.
74. Hirsch AT, Opsahl JA, Lunzer MM, Katz SA. Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction. Am J Physiol. 1999;276:H1818-H1826.
75. Hokimoto S, Yasue H, Fujimoto K, Yamamoto H, Nakao K, Kaikita K, Sakata R, Miyamoto E. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation. 1996;94:1513-1518.
76. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. Cardiac angiotensin-converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res. 1994;28:1423-1432.
77. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro Cell. 1993;95:977-984.
78. Dostal DE, Rothblum KN, Conrad KM, Cooper GR, Baker KM. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol. 1992;263:C851-C863.
79. Miyata S, Haneda T, Osaki J, Kikuchi K. Renin-angiotensin system in stretch-induced hypertrophy of cultured neonatal rat heart cells. Eur J Pharmacol. 1996;307:81-88.
80. Malhotra R, Sadoshima J, Izumo S. Mechanical stretch upregulates expression of the local renin-angiotensin system in cardiac myocytes in vitro. Circulation. 1994;90(suppl I):I-94. Abstract.
81. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
82. De Mello WC. Modulation of junctional permeability. In: De Mello WC, ed. Cell-to-Cell Communication. New York, NY: Plenum Press; 1987: 29-64.
83. De Mello WC, Altieri PI. The role of the renin-angiotensin system in the control of cell communication in heart; effects of angiotensin II and enalapril. J Cardiovasc Pharmacol. 1992;20:643-651.
84. De Mello WC. Renin-angiotensin system and cell communication in the failing heart. Hypertension. 1996;27:1267-1272.
85. De Mello WC, Cherry JR, Mannivannan S. Electrophysiologic and morphologic abnormalities in the failing heart: effect of enalapril on the electrical properties. J Card Fail. 1997;3:53-62.
86. De Mello WC. Cell-to cell communication in the failing heart. In: De Mello WC, Janse M, eds. Heart Cell Communication in Health and Disease. Boston, Mass: Kluwer Academic Publishers; 1998:149-173.
87. De Mello WC. Influence of intracellular renin on heart cell communication. Hypertension. 1995;25:1172-1177.
88. De Mello WC. Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes. Hypertension. 1998;32:976-982.
89. Buisson B, Laflamme L, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD. A G-protein is involved in the angiotensin II AT2 receptor inhibition of T-type calcium current in nondifferentiated NG108-15 cells. J Biol Chem. 1995;270:1670-1674.
90. i. Am J Physiol. 1996;271:C1340-C1349.
91. - symport through a phosphoinositide-independent mechanism in cardiac cells. J Biol Chem. 1995;270:20432-20438.